Cargando…

Update: Mepolizumab treatment in patients with severe eosinophilic asthma and prior omalizumab use

Detalles Bibliográficos
Autores principales: Albers, Frank C., Hozawa, Soichiro, Bratton, Daniel J., Yancey, Steven W., Prazma, Charlene M., Humbert, Marc, Liu, Mark C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216893/
https://www.ncbi.nlm.nih.gov/pubmed/31520471
http://dx.doi.org/10.1111/all.14048
_version_ 1783532503485644800
author Albers, Frank C.
Hozawa, Soichiro
Bratton, Daniel J.
Yancey, Steven W.
Prazma, Charlene M.
Humbert, Marc
Liu, Mark C.
author_facet Albers, Frank C.
Hozawa, Soichiro
Bratton, Daniel J.
Yancey, Steven W.
Prazma, Charlene M.
Humbert, Marc
Liu, Mark C.
author_sort Albers, Frank C.
collection PubMed
description
format Online
Article
Text
id pubmed-7216893
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-72168932020-05-13 Update: Mepolizumab treatment in patients with severe eosinophilic asthma and prior omalizumab use Albers, Frank C. Hozawa, Soichiro Bratton, Daniel J. Yancey, Steven W. Prazma, Charlene M. Humbert, Marc Liu, Mark C. Allergy Letters to the Editor John Wiley and Sons Inc. 2019-10-02 2020-04 /pmc/articles/PMC7216893/ /pubmed/31520471 http://dx.doi.org/10.1111/all.14048 Text en © 2019 The Authors Allergy Published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Letters to the Editor
Albers, Frank C.
Hozawa, Soichiro
Bratton, Daniel J.
Yancey, Steven W.
Prazma, Charlene M.
Humbert, Marc
Liu, Mark C.
Update: Mepolizumab treatment in patients with severe eosinophilic asthma and prior omalizumab use
title Update: Mepolizumab treatment in patients with severe eosinophilic asthma and prior omalizumab use
title_full Update: Mepolizumab treatment in patients with severe eosinophilic asthma and prior omalizumab use
title_fullStr Update: Mepolizumab treatment in patients with severe eosinophilic asthma and prior omalizumab use
title_full_unstemmed Update: Mepolizumab treatment in patients with severe eosinophilic asthma and prior omalizumab use
title_short Update: Mepolizumab treatment in patients with severe eosinophilic asthma and prior omalizumab use
title_sort update: mepolizumab treatment in patients with severe eosinophilic asthma and prior omalizumab use
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216893/
https://www.ncbi.nlm.nih.gov/pubmed/31520471
http://dx.doi.org/10.1111/all.14048
work_keys_str_mv AT albersfrankc updatemepolizumabtreatmentinpatientswithsevereeosinophilicasthmaandprioromalizumabuse
AT hozawasoichiro updatemepolizumabtreatmentinpatientswithsevereeosinophilicasthmaandprioromalizumabuse
AT brattondanielj updatemepolizumabtreatmentinpatientswithsevereeosinophilicasthmaandprioromalizumabuse
AT yanceystevenw updatemepolizumabtreatmentinpatientswithsevereeosinophilicasthmaandprioromalizumabuse
AT prazmacharlenem updatemepolizumabtreatmentinpatientswithsevereeosinophilicasthmaandprioromalizumabuse
AT humbertmarc updatemepolizumabtreatmentinpatientswithsevereeosinophilicasthmaandprioromalizumabuse
AT liumarkc updatemepolizumabtreatmentinpatientswithsevereeosinophilicasthmaandprioromalizumabuse